增强 cDC1 介导的抗肿瘤免疫可限制肝内胆管癌的肿瘤进展并增强 anti-PD-1 治疗疗效
Enhancing cDC1-mediated anti-tumor immunity limits tumor progression and potentiates anti-PD-1 therapy in intrahepatic cholangiocarcinoma.
我们的研究结果表明,在iCCA中,招募并激活肿瘤内cDC1是可行的,并且对于驱动抗肿瘤CD8+ T细胞免疫反应以及增强抗PD-1治疗效果至关重要。
59.2分
★★★☆☆